Immunotherapy: Open Access
Open Access

2^nd International Conference on Tumor & Cancer Immunology and Immunotherapy

July 17-18, 2017 Chicago, USA

Scientific Tracks Abstracts

• A novel oncolytic HSV-1 vector for cancer immunotherapy

  William Jia

  PDF HTML

• Diagnostic and prognostic markers in Non-Hodgkins Lymphoma

  Manal Mohamed Saber and Matthias Clauss

  PDF HTML

• Oncologic impact of postoperative delta-neutrophil index in pancreatic cancer

  Sung Hwan Lee

  PDF HTML

• The tumor microenvironment is correlated with clinicopathological traits and indicates the adjuvant chemotherapeutic efficacy of Gemcitabine in pancreatic cancer after curative Whipple procedure

  Qiaofei Liu

  PDF HTML

• Phase I clinical trials for the PD-1/MUC1 CAR-pNK92 immunotherapy

  Leiming Xia

  PDF HTML

• Phase I clinical trials for the PD-1/MUC1 CAR-pNK92 immunotherapy

  Leiming Xia

  PDF HTML

• Cancer stem cell vaccine significantly reduced local tumor relapse and prolonged animal survival in the adjuvant setting

  Qiao Li

  PDF HTML

• Emap-II-induced immune suppression in colorectal cancer

  Manal Mohamed Saber and Matthias Clauss

  PDF HTML

• Adoptively transferred B cells directly kill tumor cells via the CXCR4/CXCL12 and perforin pathways

  Lu Wen, Qiao Li, Leiming Xia, Yang Xia, Queening Chen, Yi Wang, Xiang Sun, Yangyi Bao, Steven K Lundy, Fu Dai and Alfred E Chang

  PDF HTML

• Comparative analysis of immune molecules in esophageal squamous cell carcinoma and adenocarcinoma

  Guohui Qin

  PDF HTML

• Bacteria: Friends or foes? Anticancer immune strategy by attenuated mutant strain of Salmonella Typhimurium (STMZNUABC)

  Barbara Chirullo

  PDF HTML

• Hiss Vaccine for treatment of cancer in early stages

  Hussein A Mohamed Ramadan

  PDF HTML